Alzex Neuropharma TRRI Stock
Alzex Neuropharma Price Chart
Alzex Neuropharma TRRI Financial and Trading Overview
| Alzex Neuropharma stock price | 0.29 USD |
| Previous Close | 0.15 USD |
| Open | 0.15 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.15 - 0.15 USD |
| 52 Week Range | 0.1 - 2.39 USD |
| Volume | 1 USD |
| Avg. Volume | 1.03K USD |
| Market Cap | 271 USD |
| Beta (5Y Monthly) | -33.150703 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TRRI Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.724518E-5 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Alzex Neuropharma Stock Price History
| Beta (5Y Monthly) | -33.150703 |
| 52-Week Change | -18.52% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.39 USD |
| 52 Week Low | 0.1 USD |
| 50-Day Moving Average | 0.17 USD |
| 200-Day Moving Average | 0.32 USD |
TRRI Share Statistics
| Avg. Volume (3 month) | 1.03K USD |
| Avg. Daily Volume (10-Days) | 16 USD |
| Shares Outstanding | 1.94K |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1:300 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2011 |
| Most Recent Quarter (mrq) | June 30, 2011 |
| Next Fiscal Year End | December 31, 2012 |
Profitability
| Profit Margin | 0.67% |
| Operating Margin (ttm) | -1.16% |
| Gross Margin | 9.08% |
| EBITDA Margin | 0.19% |
Management Effectiveness
| Return on Assets (ttm) | -1.63% |
| Return on Equity (ttm) | 2.84% |
Income Statement
| Revenue (ttm) | 4.73M USD |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 23.59% |
| Gross Profit (ttm) | 430.14K USD |
| EBITDA | 9.23K USD |
| Net Income Avi to Common (ttm) | 32.05K USD |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 63.5K USD |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | 690.7K USD |
| Total Debt/Equity (mrq) | 76.4 USD |
| Current Ratio (mrq) | 1.433 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 286.42K USD |
| Levered Free Cash Flow (ttm) | 198.14K USD |
Profile of Alzex Neuropharma
| Country | United States |
| State | NV |
| City | Henderson |
| Address | 2850 West Horizon Ridge |
| ZIP | 89052 |
| Phone | 720-430-4690 |
| Website | https://www.trinityresources.ca |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 11 |
Trinity Resources Inc. operates as an exploration and mining development company. The company focuses on gold, silver, and platinum group metal projects in North and South America. It has interests in the Eureka Placer Claim that is located in Eureka Creek, California. The company was formerly known as TruLan Resources Inc. and changed its name to Trinity Resources Inc. in September 2015. Trinity Resources Inc. is headquartered in Henderson, Nevada.
Q&A For Alzex Neuropharma Stock
What is a current TRRI stock price?
Alzex Neuropharma TRRI stock price today per share is 0.29 USD.
How to purchase Alzex Neuropharma stock?
You can buy TRRI shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Alzex Neuropharma?
The stock symbol or ticker of Alzex Neuropharma is TRRI.
Which industry does the Alzex Neuropharma company belong to?
The Alzex Neuropharma industry is Biotechnology.
How many shares does Alzex Neuropharma have in circulation?
The max supply of Alzex Neuropharma shares is 1.51M.
What is Alzex Neuropharma Price to Earnings Ratio (PE Ratio)?
Alzex Neuropharma PE Ratio is now.
What was Alzex Neuropharma earnings per share over the trailing 12 months (TTM)?
Alzex Neuropharma EPS is 0 USD over the trailing 12 months.
Which sector does the Alzex Neuropharma company belong to?
The Alzex Neuropharma sector is Healthcare.